169 related articles for article (PubMed ID: 27955963)
1. Association Between Imaging Characteristics and Different Molecular Subtypes of Breast Cancer.
Wu M; Ma J
Acad Radiol; 2017 Apr; 24(4):426-434. PubMed ID: 27955963
[TBL] [Abstract][Full Text] [Related]
2. Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type.
Dilorenzo G; Telegrafo M; La Forgia D; Stabile Ianora AA; Moschetta M
Eur J Radiol; 2019 Apr; 113():148-152. PubMed ID: 30927939
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of circulating tumor cells according to immunohistochemically defined molecular subtypes in advanced breast cancer.
Munzone E; Botteri E; Sandri MT; Esposito A; Adamoli L; Zorzino L; Sciandivasci A; Cassatella MC; Rotmensz N; Aurilio G; Curigliano G; Goldhirsch A; Nolè F
Clin Breast Cancer; 2012 Oct; 12(5):340-6. PubMed ID: 23040002
[TBL] [Abstract][Full Text] [Related]
4. Can breast cancer molecular subtype help to select patients for preoperative MR imaging?
Grimm LJ; Johnson KS; Marcom PK; Baker JA; Soo MS
Radiology; 2015 Feb; 274(2):352-8. PubMed ID: 25325325
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer in very young women (<30 years): Correlation of imaging features with clinicopathological features and immunohistochemical subtypes.
An YY; Kim SH; Kang BJ; Park CS; Jung NY; Kim JY
Eur J Radiol; 2015 Oct; 84(10):1894-902. PubMed ID: 26198117
[TBL] [Abstract][Full Text] [Related]
6. [Morphological features of basal-like subtype invasive carcinoma of breast].
Gao LX; Yang GZ; Ding HY; Li L
Zhonghua Bing Li Xue Za Zhi; 2008 Feb; 37(2):83-7. PubMed ID: 18681317
[TBL] [Abstract][Full Text] [Related]
7. Is there a correlation between 3T multiparametric MRI and molecular subtypes of breast cancer?
Montemezzi S; Camera L; Giri MG; Pozzetto A; Caliò A; Meliadò G; Caumo F; Cavedon C
Eur J Radiol; 2018 Nov; 108():120-127. PubMed ID: 30396643
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.
Parise CA; Bauer KR; Brown MM; Caggiano V
Breast J; 2009; 15(6):593-602. PubMed ID: 19764994
[TBL] [Abstract][Full Text] [Related]
9. Computational approach to radiogenomics of breast cancer: Luminal A and luminal B molecular subtypes are associated with imaging features on routine breast MRI extracted using computer vision algorithms.
Grimm LJ; Zhang J; Mazurowski MA
J Magn Reson Imaging; 2015 Oct; 42(4):902-7. PubMed ID: 25777181
[TBL] [Abstract][Full Text] [Related]
10. Is There a Correlation between the Presence of a Spiculated Mass on Mammogram and Luminal A Subtype Breast Cancer?
Liu S; Wu XD; Xu WJ; Lin Q; Liu XJ; Li Y
Korean J Radiol; 2016; 17(6):846-852. PubMed ID: 27833400
[TBL] [Abstract][Full Text] [Related]
11. Anthropometric factors and risk of molecular breast cancer subtypes among postmenopausal Norwegian women.
Horn J; Alsaker MD; Opdahl S; Engstrøm MJ; Tretli S; Haugen OA; Bofin AM; Vatten LJ; Asvold BO
Int J Cancer; 2014 Dec; 135(11):2678-86. PubMed ID: 24752603
[TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].
Zhang HM; Zhang BN; Xuan LX; Zhao P
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):447-51. PubMed ID: 19950556
[TBL] [Abstract][Full Text] [Related]
13. Differences in subtype distribution between screen-detected and symptomatic invasive breast cancer and their impact on survival.
Kobayashi N; Hikichi M; Ushimado K; Sugioka A; Kiriyama Y; Kuroda M; Utsumi T
Clin Transl Oncol; 2017 Oct; 19(10):1232-1240. PubMed ID: 28409323
[TBL] [Abstract][Full Text] [Related]
14. Quantitative MRI morphology of invasive breast cancer: correlation with immunohistochemical biomarkers and subtypes.
Bae MS; Seo M; Kim KG; Park IA; Moon WK
Acta Radiol; 2015 Mar; 56(3):269-75. PubMed ID: 24558165
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral heterogeneity of the distribution of kinetic parameters in breast cancer: comparison based on the molecular subtypes of invasive breast cancer.
Yamaguchi K; Abe H; Newstead GM; Egashira R; Nakazono T; Imaizumi T; Irie H
Breast Cancer; 2015 Sep; 22(5):496-502. PubMed ID: 24402638
[TBL] [Abstract][Full Text] [Related]
16. Relationships Between MRI Breast Imaging-Reporting and Data System (BI-RADS) Lexicon Descriptors and Breast Cancer Molecular Subtypes: Internal Enhancement is Associated with Luminal B Subtype.
Grimm LJ; Zhang J; Baker JA; Soo MS; Johnson KS; Mazurowski MA
Breast J; 2017 Sep; 23(5):579-582. PubMed ID: 28295860
[TBL] [Abstract][Full Text] [Related]
17. [Clinical features and prognosis analysis of different breast cancer molecular subtypes].
Yang Q; Chen J; Li HJ; Yu M; Tian CX; Lü Q
Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):42-6. PubMed ID: 21575463
[TBL] [Abstract][Full Text] [Related]
18. The characteristics of breast cancer subtypes: implications for treatment guidelines and individualized treatment strategies in China.
Zheng S; Song QK; Ren Y; Feng WL; Kong YN; Huang R; Xu F; Li J; Zhang BN; Fan JH; He JJ; Qiao YL
Appl Immunohistochem Mol Morphol; 2014; 22(5):383-9. PubMed ID: 24162264
[TBL] [Abstract][Full Text] [Related]
19. Descriptive analysis of molecular subtypes in Tunisian breast cancer.
Fourati A; Boussen H; El May MV; Goucha A; Dabbabi B; Gamoudi A; Sfar R; Rahal K; El May A; Ben Abdallah M
Asia Pac J Clin Oncol; 2014 Jun; 10(2):e69-74. PubMed ID: 23176549
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status in invasive breast cancer: a 3,198 cases study at National Cancer Center, China.
Zhu X; Ying J; Wang F; Wang J; Yang H
Breast Cancer Res Treat; 2014 Oct; 147(3):551-5. PubMed ID: 25234844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]